Literature DB >> 11880449

rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries.

Lishi Qian1, Chiyoji Abe, Tao-Ping Lin, Ming-Chih Yu, Sang-Nae Cho, Sumin Wang, James T Douglas.   

Abstract

The 81-bp region of the rpoB gene in 66 Rif(r) Mycobacterium tuberculosis isolates from China, Japan, Korea, and Taiwan was analyzed. Twelve single-nucleotide substitutions in the rpoB gene were detected. The most prevalent mutations were at Ser-531 (52%), Asp-516 (17%), and His-526 (11%). Mutations were not found in seven (11%) of the isolates. Higher mutation rates in 50 Beijing family isolates were found than in other isolates for mutations at Asp-516 (18 and 12.5%, respectively) and His-526 (12 and 6.3%, respectively). The different rates of mutation may reflect the choice of rifamycin analogs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880449      PMCID: PMC120282          DOI: 10.1128/JCM.40.3.1091-1094.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy.

Authors:  G Pozzi; M Meloni; E Iona; G Orrù; O F Thoresen; M L Ricci; M R Oggioni; L Fattorini; G Orefici
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

2.  Retrospective analysis of the Beijing family of Mycobacterium tuberculosis in preserved lung tissues.

Authors:  L Qian; J D Van Embden; A G Van Der Zanden; E F Weltevreden; H Duanmu; J T Douglas
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

3.  Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.

Authors:  S L Moghazeh; X Pan; T Arain; C K Stover; J M Musser; B N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

4.  Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas.

Authors:  V Kapur; L L Li; S Iordanescu; M R Hamrick; A Wanger; B N Kreiswirth; J M Musser
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

5.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

6.  Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece.

Authors:  P Matsiota-Bernard; G Vrioni; E Marinis
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

7.  Mutations in the rpoB gene of Mycobacterium tuberculosis that interfere with PCR-single-strand conformation polymorphism analysis for rifampin susceptibility testing.

Authors:  B J Kim; S Y Kim; B H Park; M A Lyu; I K Park; G H Bai; S J Kim; C Y Cha; Y H Kook
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

8.  Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family.

Authors:  P J Bifani; B B Plikaytis; V Kapur; K Stockbauer; X Pan; M L Lutfey; S L Moghazeh; W Eisner; T M Daniel; M H Kaplan; J T Crawford; J M Musser; B N Kreiswirth
Journal:  JAMA       Date:  1996-02-14       Impact factor: 56.272

9.  Molecular analysis of rifampin-resistant Mycobacterium tuberculosis isolated from Korea by polymerase chain reaction-single strand conformation polymorphism sequence analysis.

Authors:  H Lee; S N Cho; H E Bang; J H Lee; G H Bae; S J Kim; J D Kim
Journal:  Int J Tuberc Lung Dis       Date:  1998-07       Impact factor: 2.373

10.  Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis.

Authors:  D L Williams; L Spring; L Collins; L P Miller; L B Heifets; P R Gangadharam; T P Gillis
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more
  37 in total

1.  Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China.

Authors:  Jun Yue; Wei Shi; Jingping Xie; Yao Li; Erliang Zeng; Honghai Wang
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  PCR-based methodology for detecting multidrug-resistant strains of Mycobacterium tuberculosis Beijing family circulating in Russia.

Authors:  I Mokrousov; T Otten; A Vyazovaya; E Limeschenko; M L Filipenko; C Sola; N Rastogi; L Steklova; B Vyshnevskiy; O Narvskaya
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-03       Impact factor: 3.267

3.  Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany.

Authors:  Doris Hillemann; Tanja Kubica; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  Genetic diversity of multidrug-resistant Mycobacterium tuberculosis isolates and identification of 11 novel rpoB alleles in Taiwan.

Authors:  Ruwen Jou; Huang-Yau Chen; Chen-Yuan Chiang; Ming-Chih Yu; Ih-Jen Su
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

5.  Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants.

Authors:  Emma Huitric; Jim Werngren; Pontus Juréen; Sven Hoffner
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

6.  Assessment of mycobacterial interspersed repetitive unit-QUB markers to further discriminate the Beijing genotype in a population-based study of the genetic diversity of Mycobacterium tuberculosis clinical isolates from Okinawa, Ryukyu Islands, Japan.

Authors:  Julie Millet; Chika Miyagi-Shiohira; Nobuhisa Yamane; Christophe Sola; Nalin Rastogi
Journal:  J Clin Microbiol       Date:  2007-09-26       Impact factor: 5.948

7.  Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate.

Authors:  Jim Werngren; Sven E Hoffner
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

8.  In vitro and in vivo fitness costs associated with Mycobacterium tuberculosis RpoB mutation H526D.

Authors:  Dalin Rifat; Victoria L Campodónico; Jing Tao; James A Miller; Alpaslan Alp; Yufeng Yao; Petros C Karakousis
Journal:  Future Microbiol       Date:  2017-03-27       Impact factor: 3.165

9.  Rapid genotypic detection of rpoB and katG gene mutations in Mycobacterium tuberculosis clinical isolates from Northern India as determined by MAS-PCR.

Authors:  Anamika Gupta; Pradyot Prakash; Surya K Singh; Shampa Anupurba
Journal:  J Clin Lab Anal       Date:  2013-01       Impact factor: 2.352

10.  Pyrosequencing identification of Mycobacterium tuberculosis W-Beijing.

Authors:  Zoheira Djelouadji; Mireille Henry; Amine Bachtarzi; Nadège Foselle; Didier Raoult; Michel Drancourt
Journal:  BMC Res Notes       Date:  2009-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.